Inventor
DENEFLE PATRICE
FR19 patents
⚠️ This page may combine multiple inventors who share the name “DENEFLE PATRICE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA SA
7 patentsUS6410011B1Jun 25, 2002
Gene therapy for restenosis using an adenoviral vector
AVENTIS PHARMA SA15 citations79
USRE38556EJul 13, 2004
Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
AVENTIS PHARMA SA7 citations72
US6814962B1Nov 9, 2004
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
AVENTIS PHARMA SA3 citations59
US6893841B2May 17, 2005
Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
AVENTIS PHARMA SA2 citations58
US7998667B1Aug 16, 2011
Mutations of the parkin gene, compositions, methods and uses
AVENTIS PHARMA SA4 citations57
US9540693B2Jan 10, 2017
Mutations of the parkin gene, compositions, methods and uses
AVENTIS PHARMA SA0 citations46
US7378274B2May 27, 2008
Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses
AVENTIS PHARMA SA0 citations46
RHONE POULENC RORER SA
3 patentsUS5866551AFeb 2, 1999
Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
RHONE POULENC RORER SA40 citations94
US6033885AMar 7, 2000
Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
RHONE POULENC RORER SA38 citations92
US5792902AAug 11, 1998
Dyslipoproteinaemia-sensitized transgenic rabbit
RHONE POULENC RORER SA36 citations90
UNIV CASE WESTERN RESERVE
2 patentsUS5851521ADec 22, 1998
Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
UNIV CASE WESTERN RESERVE87 citations95
USRE37933EDec 10, 2002
Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
UNIV CASE WESTERN RESERVE0 citations51